A Bead‐Based Quantum Dot Immunoassay Integrated with Multi‐Module Microfluidics Enables Real‐Time Multiplexed Detection of Blood Insulin and Glucagon (Adv. Sci. 29/2025)

Continuous Diabetes Hormone Monitoring Quantum dot integrated real‐time enzyme‐linked immunosorbent assay (QIRT‐ELISA) platform is utilized to track blood insulin and glucagon levels in whole blood continuously, tackling the challenges associated with dynamic hormone monitoring and addressing critical gaps in diabetes research. More details can be found in article number 2412185 by Dayan Ban, Jonathan D. Schertzer, Mahla Poudineh, and co‐workers.